Diagnosis and treatment of therapy-related acute myeloid leukemia.
Strickland SA, Vey N.
Crit Rev Oncol Hematol. 2022 Mar;171:103607. doi: 10.1016/j.critrevonc.2022.103607. Epub 2022 Jan 31.
Therapy-related myeloid neoplasms.
Ganser A, Heuser M.
Curr Opin Hematol. 2017 Mar;24(2):152-158. doi: 10.1097/MOH.0000000000000316.
Therapy related myeloid neoplasm, same but different?
El Murr L, Saleh K, Pasquier F, Willekens C, Danu A, Pilorge S, Auger N, Saada V, Delaloge S, De Botton S, Pagès A, Micol JB.
Bull Cancer. 2025 Dec;112(12):1385-1393. doi: 10.1016/j.bulcan.2025.08.003. Epub 2025 Oct 8.
Therapy-related myeloid leukemia.
Godley LA, Larson RA.
Semin Oncol. 2008 Aug;35(4):418-29. doi: 10.1053/j.seminoncol.2008.04.012.
Therapy-related myeloid neoplasms.
Larson RA.
Haematologica. 2009 Apr;94(4):454-9. doi: 10.3324/haematol.2008.005157.
Therapy-related myelodysplastic syndromes and acute myeloid leukemia.
Venugopal S, DeZern AE.
Semin Hematol. 2024 Dec;61(6):379-384. doi: 10.1053/j.seminhematol.2024.09.004. Epub 2024 Sep 21.
Therapy-Related Myeloid Neoplasms.
Bueso-Ramos CE, Kanagal-Shamanna R, Routbort MJ, Hanson CA.
Am J Clin Pathol. 2015 Aug;144(2):207-18. doi: 10.1309/AJCPU1JO2LYTWUAV.
Role of TP53 mutations in the origin and evolution of therapy-related acute myeloid leukaemia.
Wong TN, Ramsingh G, Young AL, Miller CA, Touma W, Welch JS, Lamprecht TL, Shen D, Hundal J, Fulton RS, Heath S, Baty JD, Klco JM, Ding L, Mardis ER, Westervelt P, DiPersio JF, Walter MJ, Graubert TA, Ley TJ, Druley T, Link DC, Wilson RK.
Nature. 2015 Feb 26;518(7540):552-555. doi: 10.1038/nature13968. Epub 2014 Dec 8.
Therapy-related myeloid neoplasms.
Leone G, Fianchi L, Voso MT.
Curr Opin Oncol. 2011 Nov;23(6):672-80. doi: 10.1097/CCO.0b013e32834bcc2a.
Analysis of clinical and genomic profiles of therapy-related myeloid neoplasm in Korea.
Yun J, Song H, Kim SM, Kim S, Kwon SR, Lee YE, Jeong D, Park JH, Kwon S, Yun H, Lee DS.
Hum Genomics. 2023 Feb 23;17(1):13. doi: 10.1186/s40246-023-00458-8.
